Syntheses, structures and antibiotic activities of LpxC inhibitors based on the diacetylene scaffold
- 15 January 2011
- journal article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry
- Vol. 19 (2), 852-860
- https://doi.org/10.1016/j.bmc.2010.12.017
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Uridine-Based Inhibitors as New Leads for Antibiotics Targeting Escherichia coli LpxCBiochemistry, 2009
- Crystal structure of LpxC from Pseudomonas aeruginosa complexed with the potent BB‐78485 inhibitorProtein Science, 2008
- Structure of the deacetylase LpxC bound to the antibiotic CHIR-090: Time-dependent inhibition and specificity in ligand bindingProceedings of the National Academy of Sciences of the United States of America, 2007
- Phasercrystallographic softwareJournal of Applied Crystallography, 2007
- Lipid A Modification Systems in Gram-Negative BacteriaAnnual Review of Biochemistry, 2007
- MolProbity: all-atom contacts and structure validation for proteins and nucleic acidsNucleic Acids Research, 2007
- Inhibition of Lipid A Biosynthesis as the Primary Mechanism of CHIR-090 Antibiotic Activity in Escherichia coliBiochemistry, 2007
- Binding of Uridine 5‘-Diphosphate in the “Basic Patch” of the Zinc Deacetylase LpxC and Implications for Substrate Binding,Biochemistry, 2006
- The nucleotide-binding site ofAquifex aeolicusLpxCActa Crystallographica Section F Structural Biology and Crystallization Communications, 2006
- Coot: model-building tools for molecular graphicsActa Crystallographica Section D-Biological Crystallography, 2004